Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the role of azithromycin as a possible combination
partner for fosmidomycin to protect it from its susceptibility to recrudescent infections
when used as monotherapy for acute Plasmodium falciparum malaria while retaining its
excellent safety profile.